Sub-Population Insights for Efficient Trial Design & Precision Medicine
September 26, 2019
11:00AM - 12:00PM

Failed clinical trials can cost sponsors more than a billion dollars, and waste years of time developing a drug that will never get to market. However, these losses can now be mitigated through the use of artificial intelligence (AI) and machine learning-driven platforms that identify sub-populations of patients within a clinical trial who could respond positively to a treatment. When sponsors can find these populations and adapt the trial design accordingly, it can reduce the rate of trial failure, rescue a promising molecule for further development, and capture better primary and secondary endpoint data to support approval and payer valuations.

Joining this webinar you will:

  • Learn how of sub-population analysis in trial design and precision medicine can add valuable insights across the development process
  • Hear case studies from Oncology and see how the results of sub-population analysis could help sponsors make important decisions about the future of the trial earlier.
  • Looking at CNS, how sub-population analysis can contribute to accelerate trial time and lead to better future drug development
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please use this form to reach out to our media team with inquiries. Thank you.